Cargando…

Drug Induced Interstitial Lung Disease

With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwaiblmair, Martin, Behr, Werner, Haeckel, Thomas, Märkl, Bruno, Foerg, Wolfgang, Berghaus, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bentham Open 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415629/ https://www.ncbi.nlm.nih.gov/pubmed/22896776 http://dx.doi.org/10.2174/1874306401206010063

Ejemplares similares

Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension
por: Schwaiblmair, Martin, et al.
Publicado: (2012)

Differences of cardiac output measurements by open-circuit acetylene uptake in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a cohort study
por: Schwaiblmair, Martin, et al.
Publicado: (2012)

Alemtuzumab-associated diffuse alveolar damage – a case report
por: Bayas, Antonios, et al.
Publicado: (2020)

Disproportionate decline in admissions for exacerbated COPD during the COVID-19 pandemic
por: Berghaus, Thomas M., et al.
Publicado: (2022)

Acute Exacerbation in Interstitial Lung Disease
por: Leuschner, Gabriela, et al.
Publicado: (2017)

Successful long-term treatment of persistent pulmonary air leak in pneumocystis jirovecii pneumonia by unidirectional endobronchial valves
por: Bader, Stefanie, et al.
Publicado: (2018)

Drug-Induced Interstitial Lung Disease: A Systematic Review
por: Skeoch, Sarah, et al.
Publicado: (2018)

Drug induced interstitial lung disease in oncology phase I trials
por: Yonemori, Kan, et al.
Publicado: (2016)

Drug-induced interstitial lung disease: mechanisms and best diagnostic approaches
por: Matsuno, Osamu
Publicado: (2012)

Drug-Induced Interstitial Lung Disease from a Misdiagnosed Infection
por: Twohig, Patrick, et al.
Publicado: (2018)

HRCT Patterns of Drug-Induced Interstitial Lung Diseases: A Review
por: Distefano, Giulio, et al.
Publicado: (2020)

Interstitial lung disease associated with drug therapy
por: Camus, P, et al.
Publicado: (2004)

The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study
por: Kutsch, J., et al.
Publicado: (2018)

Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease
por: Dai, Hua-ping, et al.
Publicado: (2023)

Nitrofurantoin induced interstitial lung disease
por: Naidu, G. D., et al.
Publicado: (2014)

Timolol-induced interstitial lung disease
por: Patel, Hetain, et al.
Publicado: (2015)

Adalimumab induced interstitial lung disease
por: Aqsa, Anum, et al.
Publicado: (2020)

Sartan-induced interstitial lung disease
por: Dahlqvist, Caroline, et al.
Publicado: (2023)

Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
por: Behr, Jürgen
Publicado: (2021)

The genetics of interstitial lung diseases
por: Borie, Raphael, et al.
Publicado: (2019)

Drug‐induced interstitial lung disease associated with dasatinib coinciding with active tuberculosis
por: Tani, Nozomi, et al.
Publicado: (2020)

Understanding the mechanisms of drug-associated interstitial lung disease
por: Higenbottam, T, et al.
Publicado: (2004)

Diagnosis and management of drug-associated interstitial lung disease
por: Müller, N L, et al.
Publicado: (2004)

Impact of ILD-Specific Therapies on Perioperative Course in Patients with Progressive Interstitial Lung Disease Undergoing Lung Transplantation
por: Munker, Dieter, et al.
Publicado: (2023)

The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study
por: Berghaus, T. M., et al.
Publicado: (2017)

Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormality
por: Zhou, Qian, et al.
Publicado: (2023)

Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database
por: Matsumoto, Kiyoka, et al.
Publicado: (2020)

Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
por: Fukuda, Kiyoko, et al.
Publicado: (2023)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2009)

Interstitial Lung Diseases
por: Mueller-Mang, Christina, et al.
Publicado: (2017)

Comorbidities in unclassifiable interstitial lung disease
por: Prior, Thomas Skovhus, et al.
Publicado: (2022)

Interstitial Lung Disease Induced by Pazopanib Treatment
por: Ide, Shotaro, et al.
Publicado: (2017)

Metformin-Induced Eosinophilic Interstitial Lung Disease
por: Alyami, Sami M, et al.
Publicado: (2023)

Reversible Lansoprazole-Induced Interstitial Lung Disease Showing Improvement after Drug Cessation
por: Hwang, Kyu-won, et al.
Publicado: (2008)

Cost drivers in the pharmacological treatment of interstitial lung disease
por: Maqhuzu, Phillen Nozibuyiso, et al.
Publicado: (2021)

Interstitial lung disease in lysosomal storage disorders
por: Borie, Raphaël, et al.
Publicado: (2021)

Interstitial Lung Disease
Publicado: (1982)

Interstitial lung disease
por: Antoniou, Katerina M., et al.
Publicado: (2014)

Whole genome sequencing to identify predictive markers for the risk of drug-induced interstitial lung disease
por: Udagawa, Chihiro, et al.
Publicado: (2019)

Management of interstitial lung disease in patients with autoimmune disease-related interstitial lung disease
por: Dsouza, Kevin G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5duc1u378f0s8n6vjehvfun7bn